Análise de covariância para melhoria da capacidade de discriminação em ensaios de cultivares de milho

O uso de técnicas experimentais visando à precisão em detectar diferenças no rendimento de grãos é muito importante. O objetivo deste trabalho foi verificar a viabilidade da análise da covariância, como forma de reduzir o erro experimental. Foram utilizados os dados de rendimento de grãos de milho (Zea mays L.) e da população final de plantas das unidades experimentais de 313 ensaios de competição de cultivares, conduzidos no Estado do Rio Grande do Sul nos anos de 1993/96. Para fins de comparação entre a precisão da análise com e sem o uso da covariância, criou-se uma estatística denominada HD, que é igual à amplitude entre as médias estimadas das cultivares, dividida pelo valor da diferença mínima significativa (DMS) do teste de Tukey. Quanto maior for o valor de HD, melhor será a qualidade do ensaio, por permitir melhor discriminação entre as cultivares. O uso da análise da covariância elevou a estatística HD de 4,7 para 19,5, e melhorou a discriminação entre as médias ajustadas pela covariável população final de plantas.

Short-Term Effects of Using Pedometers to Increase Daily Physical Activity in Smokers: A Randomized Trial

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): Study protocol for a randomized double-blind controlled trial

Background: Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor. The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated. Angiotensin-receptor blockers (ARB) have been the preferential drugs in the management of hypertension worldwide, despite the absence of any consistent evidence of advantage over older agents, and the concern that they may be associated with lower renal protection and risk for cancer. Diuretics are as efficacious as other agents, are well tolerated, have longer duration of action and low cost, but have been scarcely compared with ARBs. A study comparing diuretic and ARB is therefore warranted.Methods/design: This is a randomized, double-blind, clinical trial, comparing the association of chlorthalidone and amiloride with losartan as first drug option in patients aged 30 to 70 years, with stage I hypertension. The primary outcomes will be variation of blood pressure by time, adverse events and development or worsening of microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new subclinical atherosclerosis and sudden death. The study will last 18 months. The sample size will be of 1200 participants for group in order to confer enough power to test for all primary outcomes. The project was approved by the Ethics committee of each participating institution.Discussion: The putative pleiotropic effects of ARB agents, particularly renal protection, have been disputed, and they have been scarcely compared with diuretics in large clinical trials, despite that they have been at least as efficacious as newer agents in managing hypertension. Even if the null hypothesis is not rejected, the information will be useful for health care policy to treat hypertension in Brazil. Clinical trials registration number: ClinicalTrials.gov: NCT00971165. © 2011 Fuchs et al; licensee BioMed Central Ltd.